IndraLab

Statements


| 1

eidos
"We observed that the decitabine treatment reduced the fraction of cells with prolonged delay times in USP18 induction , which is in part due to earlier USP18 upregulation ( Figure 5 - - figure supplement 4 ) , supporting that the promoter methylation inhibits USP18 induction ( Figure 5D ) ."